Advertisement
Advertisement
U.S. Markets closed
S&P Futures
4,272.75 -8.25 (-0.19%) Dow Futures
33,658.00 -60.00 (-0.18%) Nasdaq Futures
13,549.25 -28.50 (-0.21%) Russell 2000 Futures
2,011.80 -5.10 (-0.25%) Crude Oil
91.46 -0.63 (-0.68%) Gold
1,812.10 -3.40 (-0.19%)
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 21.76 |
| Open | 21.90 |
| Bid | 9.06 x 800 |
| Ask | 24.00 x 900 |
| Day's Range | 21.77 - 22.74 |
| 52 Week Range | 15.44 - 26.90 |
| Volume | |
| Avg. Volume | 203,450 |
| Market Cap | N/A |
| Beta (5Y Monthly) | 1.42 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 09, 2015 |
| 1y Target Est | 29.15 |
- PR Newswire
Artivion Reports Second Quarter 2022 Financial Results
Second Quarter and Recent Business Highlights:
- PR Newswire
Artivion to Participate in Upcoming Investor Conferences
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.
- Zacks
What Makes Artivion (AORT) a New Buy Stock
Artivion (AORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
